8-KEarnings & ResultsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Oct 22, 2014)

Filed October 22, 2014For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed an 8-K on October 22, 2014, to announce its financial results for the third quarter ended September 30, 2014. The key takeaway for investors is that the company released its Q3 2014 financial results via a press release, which is furnished as an exhibit with this filing. Investors and interested parties should refer to this press release for detailed financial performance and operational highlights. While the 8-K itself does not contain the specific financial figures, it serves as the official notification that these results have been made public. The information within the press release is crucial for understanding the company's performance, including revenue, profitability, and any segment-specific achievements or challenges encountered during the quarter. The filing also clarifies that this information is furnished and not deemed 'filed' for certain regulatory purposes.

Key Highlights

  • 1Boston Scientific Corp (BSX) announced its third quarter 2014 financial results on October 22, 2014.
  • 2The results were disclosed via a press release, furnished as Exhibit 99.1 to the 8-K filing.
  • 3Investors should consult the provided press release for detailed financial performance and operational updates for Q3 2014.
  • 4The 8-K filing itself does not contain the specific financial metrics, but rather directs to the press release.
  • 5The information furnished is not considered 'filed' for the purposes of Section 18 of the Exchange Act.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce and provide access to Boston Scientific Corporation's financial results for the third quarter ended September 30, 2014. It serves as a notification that these results have been publicly disclosed.

The actual financial results for the third quarter of 2014 are contained within the press release issued by Boston Scientific Corporation on October 22, 2014, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should review this press release for detailed financial information.

No, the information contained in Item 2.02 of this Current Report and in Exhibit 99.1 (the press release) is furnished and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. It also will not be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Exchange Act.